New combo pill aims to simplify cholesterol control for thousands
NCT ID NCT06314919
First seen Nov 01, 2025 · Last updated May 26, 2026 · Updated 32 times
Summary
This study is testing a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe) in over 8,600 people with high cholesterol. The goal is to see how well the pill helps patients reach their target LDL (bad) cholesterol levels in real-world conditions. Participants are already on cholesterol treatment and are switching to this fixed-dose combination for convenience or dose adjustment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ewha Womans University Seoul Hospital
RECRUITINGSeoul, South Korea
Contact
Conditions
Explore the condition pages connected to this study.